公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2009 | National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital | CHIA-CHI LIN ; CHIH-HSIN YANG ; ANN-LII CHENG ; Chan W.-K.; HONG-NERNG HO | Drug Information Journal | 3 | 2 | |
2017 | National policies fostering hospice care increased hospice utilization and reduced the invasiveness of end-of-life care for cancer patients | YU-YUN SHAO ; Hsiue E.H.-C.; CHIH-HUNG HSU ; CHIEN-AN YAO ; Chen H.-M.; Lai M.-S.; ANN-LII CHENG | Oncologist | 21 | 17 | |
2011 | Needs for hepatocellular carcinoma control policy in the Asia-Pacific region | Bridges J.F.P.; Joy S..; Gallego G.; Kudo M.; Ye S.-L.; Han K.-H.; ANN-LII CHENG ; Blauvelt B. | Asian Pacific Journal of Cancer Prevention | 25 | | |
2016 | Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells | Cho C.-Y.; Huang J.-S.; Shiah S.-G.; Chung S.-Y.; Lay J.-D.; Yang Y.-Y.; Lai G.-M.; ANN-LII CHENG ; Chen L.-T.; Chuang S.-E. | RNA | 33 | 32 | |
2021 | Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma | SHIH-HUNG YANG ; LI-CHUN LU ; HSIANG-FONG KAO ; BANG-BIN CHEN ; TING-CHUN KUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; Bai, Li-Yuan; ANN-LII CHENG ; KUN-HUEI YEH | Oncoimmunology | 3 | 4 | |
2008 | NF-κB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells | Gao M.; Yeh P.Y.; YEN-SHEN LU ; Chang W.C.; Kuo M.-L.; ANN-LII CHENG | Biochemical and Biophysical Research Communications | 23 | 19 | |
2022 | Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial | Yau, Thomas; Park, Joong-Won; Finn, Richard S; ANN-LII CHENG ; Mathurin, Philippe; Edeline, Julien; Kudo, Masatoshi; Harding, James J; Merle, Philippe; Rosmorduc, Olivier; Wyrwicz, Lucjan; Schott, Eckart; Choo, Su Pin; Kelley, Robin Kate; Sieghart, Wolfgang; Assenat, Eric; Zaucha, Renata; Furuse, Junji; Abou-Alfa, Ghassan K; El-Khoueiry, Anthony B; Melero, Ignacio; Begic, Damir; Chen, Gong; Neely, Jaclyn; Wisniewski, Tami; Tschaika, Marina; Sangro, Bruno | The Lancet. Oncology | 444 | 433 | |
2013 | No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply | SUNG-HSIN KUO ; Weng W.-H.; KUN-HUEI YEH ; Chen L.-T.; ANN-LII CHENG | Genes Chromosomes and Cancer | 1 | 1 | |
2014 | No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen | WEI-WU CHEN ; Chen H.-M.; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; Lai M.-S.; YEN-SHEN LU | Breast Cancer Research and Treatment | 10 | 8 | |
2012 | Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group | Kim, Seok Jin; Moon, Joon Ho; Kim, Hawk; Kim, Jin Seok; Hwang, Yu Yan; Intragumtornchai, Tanin; Issaragrisil, Surapol; Kwak, Jae Yong; Lee, Je Jung; Won, Jong Ho; Reksodiputro, Arry Harryanto; Lim, Soon Thye; ANN-LII CHENG ; Kim, Won Seog; Kwong, Yok Lam | Leukemia & Lymphoma | 32 | 26 | |
2021 | Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancer | Kasper S.; Foch C.; Messinger D.; Esser R.; Lamy F.-X.; Rothe V.; Chen W.; ANN-LII CHENG ; Rouyer M.; Brodowicz T.; Zielinski C. | European Journal of Cancer | 7 | 8 | |
2019 | Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma | SUNG-HSIN KUO ; MING-SHIANG WU ; KUN-HUEI YEH ; CHUNG-WU LIN ; PING-NING HSU ; Chen L.-T.; ANN-LII CHENG | Cancers | 21 | 22 | |
2023 | Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancer | KUO-HSING CHEN ; CHIA-LANG HSU ; Su, Yu-Li; CHANG-TSU YUAN ; LIANG-IN LIN ; JIA-HUEI TSAI ; YI-HSIN LIANG ; ANN-LII CHENG ; KUN-HUEI YEH | British journal of cancer | 0 | 0 | |
2005 | Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21) | KUN-HUEI YEH ; SUNG-HSIN KUO ; Chen, Li-Tzong; TSUI-LIEN MAO ; SHIN-LIAN DOONG ; MING-SHIANG WU ; Hsu, Hui-Chen; Tzeng, Yi-Shin; Chen, Chi-Long; JAW-TOWN LIN ; ANN-LII CHENG | Blood | 71 | 59 | |
2004 | Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas | SUNG-HSIN KUO ; Chen L.-T.; KUN-HUEI YEH ; MING-SHIANG WU ; Hsu H.-C.; Yeh P.-Y.; TSUI-LIEN MAO ; Chen C.-L.; SHIN-LIAN DOONG ; Lin J.-T.; ANN-LII CHENG | Journal of Clinical Oncology | 63 | 53 | |
2013 | Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κb is associated with a poor prognosis of pancreatic cancer | SHIH-HUNG YANG ; CHIH-HUNG HSU ; JEN-CHIEH LEE ; YU-WEN TIEN ; SUNG-HSIN KUO ; ANN-LII CHENG | Oncology (Switzerland) | 24 | 20 | |
2001 | Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin | Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Chyi Song Y.; ANN-LII CHENG | Biochemical and Biophysical Research Communications | 34 | 35 | |
2009 | Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival | Ying-Chun Shen ; Hu F.-C.; YUNG-MING JENG ; YU-TING CHANG ; ZHONG-ZHE LIN ; MING-CHU CHANG ; CHIUN HSU ; ANN-LII CHENG | Cancer Epidemiology Biomarkers and Prevention | 21 | 20 | |
2010 | O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers | PEI-FANG WU; KUAN-TING KUO ; LU-TING KUO ; YI-TING LIN; WEI-CHUNG LEE; YEN-SHEN LU ; CHIH-HSIN YANG ; RUEY-MEEI WU ; YONG-KWANG TU ; JUI-CHANG TASI ; HAM-MIN TSENG; SHENG-HONG TSENG ; ANN-LII CHENG ; CHING-HUNG LIN | Lung Cancer | 26 | 26 | |
2006 | An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer | Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; KUN-HUEI YEH ; Kao W.Y.; Chen L.T.; ANN-LII CHENG | British Journal of Cancer | 13 | 13 | |